J.W. Cole Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,090
Closed -$516K 961
2025
Q4
$516K Sell
5,090
-3,178
-38% -$255K 0.01% 889
2025
Q3
$452K Sell
8,268
-966
-10% -$48.3K 0.01% 1029
2025
Q2
$491K Sell
9,234
-482
-5% -$24.5K 0.01% 921
2025
Q1
$421K Buy
9,716
+1,134
+13% +$57.4K 0.01% 820
2024
Q4
$482K Buy
8,582
+1,073
+14% +$66.8K 0.02% 613
2024
Q3
$512K Buy
+7,509
New +$424K 0.02% 590
2021
Q3
Sell
-2,044
Closed -$254K 527
2021
Q2
$254K Buy
2,044
+426
+26% +$50.8K 0.02% 628
2021
Q1
$213K Sell
1,618
-100
-6% -$13.7K 0.02% 610
2020
Q4
$228K Buy
+1,718
New +$208K 0.02% 561

Other funds holding EXAS

J.W. Cole Advisors's EXAS Position: Q1 2026 in Review

J.W. Cole Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 5,090 shares — an estimated $516K sold.

J.W. Cole Advisors first reported a position in EXAS in Q4 2020 and held it in 9 quarters. The position peaked at $516K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • J.W. Cole Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • J.W. Cole Advisors sold 5,090 Exact Sciences shares in Q1 2026, an estimated $516K.
  • J.W. Cole Advisors first reported a position in Exact Sciences in Q4 2020 and held it in 9 quarters.
  • J.W. Cole Advisors's Exact Sciences position peaked at $516K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on J.W. Cole Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.